Matthew Schultz

Matthew Schultz is a Bioinformatics PhD with extensive experience in analyzing next-generation sequencing data to address various biological questions. They served as a Bioinformatics Scientist at Human Longevity, Inc., where they developed the company’s first sequencing analysis workflow and mutation report. Matthew held senior bioinformatics roles at Invitae and Guardant Health, leading efforts for gene screening and diagnostic capabilities. Currently, they are the Director of Bioinformatics at Ambry Genetics, focusing on clinical development. Matthew's academic background includes a PhD from the University of California, San Diego, focusing on bioinformatics and systems biology.